Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Equity: 2011-2024

Historic Return on Equity for OptimizeRx (OPRX) over the last 14 years, with FY2024 value amounting to 0.13%.

  • OptimizeRx's Return on Equity rose 3100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.13% for FY2024, which is 100.0% up from last year.
  • Per OptimizeRx's latest filing, its Return on Equity stood at 0.13% for FY2024, which was up 100.0% from 0.14% recorded in FY2023.
  • OptimizeRx's 5-year Return on Equity high stood at 0.0% for FY2021, and its period low was 0.14% during FY2023.
  • Over the past 5 years, OptimizeRx's median Return on Equity value was 0.09% (recorded in 2022), while the average stood at 0.08%.
  • As far as peak fluctuations go, OptimizeRx's Return on Equity surged by 500bps in 2020, and later crashed by -900bps in 2022.
  • Annual analysis of 5 years shows OptimizeRx's Return on Equity stood at 0.05% in 2020, then surged by 109bps to 0.0% in 2021, then tumbled by -2231bps to 0.09% in 2022, then plummeted by -57bps to 0.14% in 2023, then grew by 10bps to 0.13% in 2024.
  • Its Return on Equity stands at 0.13% for FY2024, versus 0.14% for FY2023 and 0.09% for FY2022.